Advances in basic science understanding of mother-to-child HIV-1 transmission

Current Opinion in HIV and AIDS

Volumn 3, Issue 2, 2008, Pages 146-150

  Walter, Jan ^a   Kuhn, Louise ^b   Aldrovandi, Grace M ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Columbia University ^*  (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Breast milk; Cell associated HIV; Mother to child transmission; Neutralizing antibody; Pediatric HIV 1

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTHER CHILD RELATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 40049107005     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3282f50bb2     Document Type: Review

References (54)

1. Becquet R, Newell M-L. Prevention of postnatal HIV infection:infant feeding and antiretroviral interventions. Curr Opin HIV AIDS 2007; 2:361-366.
2. Wolinsky SM, Wike CM, Korber BT, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992; 255:1134-1137.
3. Margolis L, Shattock R. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat Rev Microbiol 2006; 4:312-317.
4. Dickover RE, Garratty EM, Plaeger S, et al. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001; 75:2194-2203.
5. Long EM, Martin HL Jr, Kreiss JK, et al. Gender differences in HIV-1 diversity at time of infection. Nat Med 2000; 6:71-75.
6. Sagar M, Lavreys L, Baeten JM, et al. Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol 2003; 77:12921-12926.
7. Burkhard MJ, Dean GA. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 2003; 1:15-29.
8. Lehman DA, Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 2007; 17:381-403.
9. Shapiro RL, Ndung'u T, Lockman S, et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 2005; 192:713-719.
10. Koulinska IN, Villamor E, Chaplin B, et al. Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr 2006; 41:93-99. A well-conducted case-control study comparing the risks of cell-associated versus cell-free virus in breast milk.
11. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 2004; 190:1880-1888.
12. Gantt S, Shetty AK, Seidel KD, et al. Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk. J Infect Dis 2007; 196:570-576. An excellent study showing the associations of different markers of mastitis with cell-free and cell-associated virus in breast milk.
13. Semrau K, Ghosh M, Kankasa C, et al. Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first four months of breastfeeding. J Acquir Immune Defic Syndr 2007; In press.
14. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 1993; 197:624-629.
15. LaRussa P, Magder LS, Pitt J, et al. Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission. J Acquir Immune Defic Syndr 2002; 30:88-94.
16. Eshleman SH, Lie Y, Hoover DR, et al. Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women. J Infect Dis 2006; 193:1512-1515.
17. Koulinska IN, Villamor E, Msamanga G, et al. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and nonrecombinant HIV-1 genotypes. Virus Res 2006; 120:191-198.
18. Eshleman SH, Church JD, Chen S, et al. Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. J Acquir Immune Defic Syndr 2006; 42:518-521.
19. Yang C, Li M, Newman RD, et al. Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 2003; 17:1667-1674.
20. Eshleman SH, Becker-Pergola G, Deseyve M, et al. Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 Study). J Infect Dis 2001; 184:914-917.
21. WHO/FCH/CAH/00.13. Mastitis: causes and management, 13th ed. Geneva, Switzerland: World Health Organization; 2000.
22. Fetherston C. Mastitis in lactating women: physiology or pathology? Breastfeed Rev 2001; 9:5-12.
23. Barbosa-Cesnik C, Schwartz K, Foxman B. Lactation mastitis. JAMA 2003; 289:1609-1612.
24. Southern SO. Milk-borne transmission of HIV. Characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol 1998; 1:328-337.
25. Goldman AS, Thorpe LW, Goldblum RM, et al. Anti-inflammatory properties of human milk. Acta Paediatr Scand 1986; 75:689-695.
26. Thea DM, Aldrovandi G, Kankasa C, et al. Postweaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS 2006; 20:1539-1547. The first study analysing the effects of rapid weaning on breast milk viral load and in addition showing a higher mortality and morbidity associated with the peri-weaning period. This study indicates that rapid weaning may not be appropriate.
27. Dorosko SM, Thea DM, Saperstein G, et al. Veterinary field test as screening tool for mastitis and HIV-1 viral load in breastmilk from HIV-infected Zambian women. Breastfeed Med 2007; 2:172-176.
28. Green MJ, Green LE, Schukken YH, et al. Somatic cell count distributions during lactation predict clinical mastitis. J Dairy Sci 2004; 87:1256-1264.
29. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007; 369:1107-1116. A well conducted cohort study that demonstrated the benefits of exclusive breastfeeding compared with non-exclusive breastfeeding.
30. Kuhn L, Aldrovandi G, Sinkala M, et al. High uptake of exclusive breastfeeding and reduced postnatal HIV transmission: prospective results from the Zambia exclusive breastfeeding study. In: 4th International AIDS Society Conference. Sydney, Australia, 22-25 July 2007. A large cohort study demonstrating the benefits of exclusive breastfeeding compared with non-exclusive breastfeeding.
31. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802.
32. Rollins NC, Filteau SM, Coutsoudis A, et al. Feeding mode, intestinal permeability, and neopterin excretion: a longitudinal study in infants of HIV-infected South African women. J Acquir Immune Defic Syndr 2001; 28:132-139.
33. Villamor E, Koulinska IN, Furtado J, et al. Long-chain n 6 polyunsaturated fatty acids in breast milk decrease the risk of HIV transmission through breastfeeding. Am J Clin Nutr 2007; 86:682-689. A detailed analysis of the association of fatty acids in breast milk with the risk of mother-to-child HIV transmission.
34. Kuhn L, Coutsoudis A, Trabattoni D, et al. Synergy between mannose-binding lectin gene polymorphisms and supplementation with vitamin A influences susceptibility to HIV infection in infants born to HIV-positive mothers. Am J Clin Nutr 2006; 84:610-615.
35. Kuhn L, Trabattoni D, Kankasa C, et al. Alpha-defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr 2005; 39:138-142.
36. Kuhn L, Schramm DB, Donninger S, et al. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS 2007; 21:1753-1761.
37. Meddows-Taylor S, Donninger SL, Paximadis M, et al. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 2006; 87:2055-2065. The first study showing that protein levels of CCL3 are associated with protection against HIV transmission.
38. Tiemessen CT, Kuhn L. CC chemokines and protective immunity: insights gained from mother-to-child transmission of HIV. Nat Immunol 2007; 8:219-222.
39. Kuhn L, Trabattoni D, Kankasa C, et al. Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Pediatr 2006; 149:611-616.
40. Walter J, Kuhn L, Ghosh MK, et al. Low and undetectable breast milk interleukin-7 concentrations are associated with reduced risk of postnatal HIV transmission. J Acquir Immune Defic Syndr 2007; 46:200-207.
41. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371. An important paper describing the association between microbial translocation in the gut and immune activation during chronic HIV infection.
42. Sinkala M, Kuhn L, Kankasa C, et al. No benefit of early cessation of breastfeeding at 4 months on HIV-free survival of infants born to HIV-infected mothers in Zambia: the Zambia Exclusive Breastfeeding Study. In: 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA, USA, 25-28 February 2007. Abstract 74.
43. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006; 296:794-805. A large trial exploring alternatives to formula feeding in Botswana and showing that neither breastfeeding plus zidovudine nor formula feeding is safe.
44. Go LL, Albanese CT, Watkins SC, et al. Breast milk protects the neonate from bacterial translocation. J Pediatr Surg 1994; 29:1059-1063; discussion 1063-1064.
45. Wu X, Parast AB, Richardson BA, et al. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 2006; 80:835-844. A well conducted study showing that transmission is predominantly by escape mutants to maternal neutralizing antibodies and is associated with structural changes in the envelope domain of HIV.
46. Dickover R, Garratty E, Yusim K, et al. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants. J Virol 2006; 80:6525-6533. This study presents convincing evidence that neutralizing antibodies may confer protection against intrauterine transmission.
47. Lathey JL, Tsou J, Brinker K, et al. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission. J Infect Dis 1999; 180:344-350.
48. Hengel RL, Kennedy MS, Steketee RW, et al. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS Res Hum Retroviruses 1998; 14:475-481.
49. MacDonald KS, Embree J, Njenga S, et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998; 177:551-556.
50. Kuhn L, Abrams EJ, Palumbo P, et al. Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression. AIDS 2004; 18:1281-1289.
51. Tiemessen CT, Kuhn L. Immune pathogenesis of pediatric HIV-1 infection. Curr HIV/AIDS Rep 2006; 3:13-19.
52. Schramm DB, Meddows-Taylor S, Gray GE, et al. Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses. Clin Vaccine Immunol 2007; 14:348-354.
53. Legrand FA, Nixon DF, Loo CP, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 2006; 1:e102.
54. Richardson BA, John-Stewart GC, Hughes JP, et al. Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis 2003; 187:736-740.